0.8187
Akari Therapeutics Plc Adr Azioni (AKTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
3.525
|
- | - | - | - |
Operating Income/Loss |
33.21%
-3.525
|
-5.278 | -2.927 | -7.449 | -5.989 |
Nonoperating Income/Loss |
111.95%
-0.18
|
1.506 | 0.032 | -0.109 | 0.423 |
Income/Loss From Continuing Operations Before Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
|
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
Diluted Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
Basic Earnings Per Share |
-
|
- | - | - | - |
Diluted Earnings Per Share |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):